ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Archives of Disease in Childhood 2006;91(Supplement 1):A80-A82
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Oncology and haematology

The first 150 words of the full text of this article appear below.


G223 DOES TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD MAKE A DIFFERENCE? A SYSTEMATIC REVIEW OF RANDOMISED CONTROLLED TRIALS
EvaStuwe1, RicharCooke2, RusselKeenan1.1Royal Liverpool Childrens Hospital, Liverpool, UK; 2Liverpool Womens Hospital, Liverpool, UK

Background: The chronic form of idiopathic thrombocytopenic purpura (ITP) occurs in approximately 10–20% of children with ITP. There is no consensus on the treatment. Life threatening complications of ITP related to bleeding are uncommon but potentially devastating. Spontaneous remissions even after years have been described. No systematic review on the effect of different treatment regimes on morbidity or mortality or prevention of the chronic course of the disease has been completed so far.

Aim: To compare the effect of different treatment regimes or non-treatment on the risk of death and major haemorrhage attributable to chronic ITP and the remission rate.

Method: Randomised controlled trials (RCTs) were identified from the Cochrane Library, PubMed, Medline, Embase, Cinahl, Amed, and reference lists from identified studies and review articles. All RCTs or quasi-randomised trials on the treatment . . . [Full text of this article]




This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
R. Skinner, W H. B Wallace, and G. Levitt
Long-term follow-up of children treated for cancer: why is it necessary, by whom, where and how?
Arch. Dis. Child., March 1, 2007; 92(3): 257 - 260.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
R Phillips, R Skinner, and J C Chisholm
Treating low-risk febrile neutropenia: Jenny's story
Arch. Dis. Child., January 1, 2007; 92(1): 7 - 8.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health